Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: STEVEN BERNITZ - ORGANOGENESIS INC (ORG).


(PAL233) STEVEN BERNITZ - ORGANOGENESIS INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
 (ORG). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 6/2/02. Tickers featured: ORG. Complete text approximately 3000 words. Document # PAL233.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:CEO INTERVIEW: STEVEN BERNITZ - ORGANOGENESIS INC (ORG).(Brief Article)
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 10, 2002
Words:88
Previous Article:ANALYST INTERVIEW: BIOTECHNOLOGY: INDUSTRY OVERVIEW: CAROLYN PRATT - NEEDHAM & CO.
Next Article:CEO INTERVIEW: W.SCOTT HARKONEN - INTERMUNE PHARMACEUTICALS INC (ITMN).
Topics:



Related Articles
PHILIP M. LAUGHLIN - ORGANOGENESIS INC (ORG).
ORGANOGENESIS 4TH QUARTER APLIGRAF SALES SURPASS 4000 UNITS.
Organogenesis Inc. Provides Business Update; Launch of FortaPerm-TM- Marks New Stage for Company.
Organogenesis Inc. Promotes Steven Bernitz to Executive Vice President and Chief Operating Officer.
Organogenesis Inc. Receives FDA Marketing Clearance for Rotator Cuff Repair Product; Biomet Expected to Introduce Product Mid-2002.
Organogenesis receives FDA 510(k) clearance to market rotator cuff repair patch.
Organogenesis Inc. Appoints Steven B. Bernitz President and Chief Executive Officer.
Organogenesis to Present at Needham Biotechnology Conference on June 4, 2002.
Organogenesis Inc. Responds to Patent Infringement Lawsuit Action Against Cook Biotech Commenced in Boston.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles